Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Delcath Systems, Inc. (DCTH : NSDQ)

• Company Description    Delcath Systems, Inc. has developed a system, the Delcath system, to isolate the liver from the general circulatory system and to administer chemotherapy and other therapeutic agents directly to the liver. Number of Employees: 156

• Price / Volume Information    Yesterday's Closing Price: $12.22 Daily Weekly Monthly 20 Day Moving Average: 396,571 shares Shares Outstanding: 34.52 (millions) Market Capitalization: $421.86 (millions) Beta: 0.49 52 Week High: $13.74 52 Week Low: $8.12 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -0.81% -1.54% 12 Week 17.73% 14.50% Year To Date 20.99% 13.72%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 566 QUEENSBURY AVENUE - QUEENSBURY,NY 12804 USA ph: 518-743-8892 fax: 212-489-2102 investorrelations@delcath.com http://www.delcath.com

• General Corporate Information    Officers Gerard Michel - Chief Executive Officer and Director John R. Sylvester - Chairman of the Board Sandra Pennell - Chief Financial Officer Elizabeth Czerepak - Director Steven Salamon - Director Peer Information Delcath Systems, Inc. (ABMD) Delcath Systems, Inc. (DMDS) Delcath Systems, Inc. (CPWY.) Delcath Systems, Inc. (EQUR) Delcath Systems, Inc. (ECIA) Delcath Systems, Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 24661P807 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/05/26 Share - Related Items Shares Outstanding: 34.52 Most Recent Split Date: 12.00 (0.00:1) Beta: 0.49 Market Capitalization: $421.86 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.29 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.88 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/05/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: 1,222.00 PEG Ratio: - Price Ratios Price/Book: 3.74 Price/Cash Flow: 233.77 Price / Sales: 4.66 EPS Growth vs. Year Ago Period: -200.00% vs. Previous Quarter: 40.00% Sales Growth vs. Year Ago Period: 26.33% vs. Previous Quarter: 20.58% ROE 06/30/26 - - 03/31/26 - 0.51 12/31/25 - 2.63 ROA 06/30/26 - - 03/31/26 - 0.46 12/31/25 - 2.39 Current Ratio 06/30/26 - - 03/31/26 - 11.24 12/31/25 - 10.92 Quick Ratio 06/30/26 - - 03/31/26 - 10.33 12/31/25 - 9.98 Operating Margin 06/30/26 - - 03/31/26 - 0.62 12/31/25 - 3.17 Net Margin 06/30/26 - - 03/31/26 - 0.62 12/31/25 - 3.17 Pre-Tax Margin 06/30/26 - - 03/31/26 - 1.48 12/31/25 - 4.12 Book Value 06/30/26 - - 03/31/26 - 3.27 12/31/25 - 3.15 Inventory Turnover 06/30/26 - - 03/31/26 - 1.23 12/31/25 - 1.22 Debt-to-Equity 06/30/26 - - 03/31/26 - 0.00 12/31/25 - 0.00 Debt-to-Capital 06/30/26 - - 03/31/26 - 0.00 12/31/25 - 0.00

Powered by Zacks Investment Research ©